Arun Kaul, Chief Investment Officer, AK Global Investment Management
9:10-9:25, Tour Trader Pro
Timothy LeGendre, CFA, Founder - TourTrader Pro
9:25-9:50, Fractionalized Art Equity Strategies
Alan Snyder, Managing General Partner - Shinnecock Partners
9:50-10:35, Manager Selection 2024
Barbara Biddle McEvilley, MBA, Founder & CEO - Nova Skye Consulting
Maureen Downey, Managing Director, Alternative Asset Investment - The Beneficient Company Group, L.P.
Matthew Mangan, Partner - K&L Gates
Moderator - Gary Sawka, Founding Partner - Crimson Growth Partners
10:35-11:00, Delivering Secondary Immune Checkpoint Therapies using Precision Based Approach
Ronan O'Hagan, President - Bectas Therapeutics
11:00-11:50, Alternative Credit 2024
Suzanne Murphy, Managing Director - Lampe Conway
William Timmerman, Managing Director - Xnergy
Shant Sood, Managing Partner, Co-Founder - Sanctum Capital Management
Moderator - Mariia Eroshin, Managing Director - Certuity
11:50 - 12:15 pm , Opportunities in Venture Capital
Rachna Dayal, Managing Partner - Sugati Ventures
12:15 - 12:30 pm , Rare Disease Investments
Alex Silver , Managing Partner - Ananym Capital Management
12:30 - 12:55 pm , EIR Biopharma
Anthony Cataldo, Chairman & Chief Executive Officer - EIR Biopharma, Inc.
Martin Schroeder, President & CFO, CSO - EIR Biopharma, Inc.
12:55 - 1:10 pm , Rare Disease Investments
Mehran Khorsandi, MD, Executive Chairman and Chief Medical Officer - Advanced Bifurcation Systems, Inc.
1:10 - 2:10 p.m. , Healthcare 2024
Ken Richards, Chief Administrative Officer/CFO - Advanced Bifurcation Systems, Inc.
Norm Friedland, Esq, Co-Founder, FullSky Partners
John Cataldi, Managing Partner - Native American Venture Fund
Patrick Maguire, Board Member, Chairman, CEO, Entrepreneur - MaguireDevicePharma.com
Moderator - Dr Barbara Handelin, CEO and Founder - The 90 / 10 Institute
2:10 - 2:35 pm , Sonodynamic Therapy, a new non-invasive modality to treat cancer
Mark DeSouza, President and CEO - SonALAsense
2:35 - 3:00 pm , New Oncology Treatments for 2024
Jonathan Northrup, CEO, CoFounder, Board Member - Stingray Therapeutics
3:00 - 3:25 pm , Human Recombinant Decorin to Treat Fibrotic Diseases
Deborah Chan Mangan, Athena Investments
Jay D. Shaffer, CCIM, Partner & Co-Founder - Colton Commercial & Partners, Inc.
Ken Kecskes, Partner - K&L Gates
Lillian Chan, Founder - Yooney, Block Ledger
Dr. Lawrence A. Souza, DBA/CRE/RICS/CCIM. Senior -Real Estate/Financial/Investment Economist/Advisor/Broker
Moderator - Matthew Kessler, Managing Partner, PACE Capital- CRE Capital Markets Debt & Structured Finance
4:10 - 4:35 pm , New Opportunities in Energy
Greg Pletz, Founder and Managing Partner - Energy Finance Partners Date: Wednesday January 10th, 2024 Time: 9:00 AM to 4:30 PM Pacific Time
Dory Wiley, President & CEO - Commerce Street Holdings
Tom O'Donnell, Chief Operating Officer - 3d Capital Management
Cory Reader, Chief Investment Officer at Omnia Capital Management, Inc.
Tyson Halsey, Managing Member - Income Growth Advisors
Julia Valentine, Chief Operating Officer and Chief Technology Officer - AlphaMille
Ron D'vari, Executive Chairman, Chief Investment Officer, Co-Founder at NewOak
Moderator - Arthur Mrozowski, Silicon Hill Ventures
12:15 - 12:30 p.m. , InCellDX
Chris Wheeler, CFO - IncellDx
12:30 - 1:20 pm , Venture Capital 2024
Jayon Wang, Partner - Norwood Point Ventures
Lu Zhang, General Partner - Fusion Fund
Eric Ball, PhD, General Partner - Impact Venture Capital
Moderator - Mark Heil | Managing Director - Pickwick Capital Partners, LLC
1:20 - 2:20 , ESG 2.0
Ahmed Qureshi, Founder - Valorant Health
Jon Peters, Managing Director - Custom Carbon
Jawahar M. Gidwani, Chairman and Chief Executive Officer - QuSwami, Inc.
Julie Cane, Chief Executive Officer - DEMOCRACY INVESTMENTS LLC
Moderator - Tyson Halsey, Managing Member - Income Growth Advisors,
4:00 - 5:00 p.m. , Open
Date: Thursday January 11th, 2024 Time: 9:00 AM to 12:00 PM Pacific Time
ALAN SNYDER
Managing General Partner
Shinnecock Partners
JOHN CATALDI
Managing Partner
Native American Venture Fund
DEBORAH CHAN MANGAN
Principal & Managing Director
Athena Investment Group
SCOTT SCHORER
President & Chief Executive Officer
- Gila Therapeutics
K&L Gates
4 Embarcadero Ctr, San Francisco, CA 94111
PLATINUM SPONSORS
BRONZE AND SEASONAL SPONSORS
We Engage Family Office and Institutional Investors
FUND AND DEAL SPONSORS
Share information about their broad outlook while providing narrow and specific insight into their core subject matter expertise and focus